Physician profile
Bryan Baines
NPI 1205839461
$2,516.95
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $512 · 2021: $956 · 2022: $809.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.68 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $270.20 | 2020-2022 | |
| Lilly USA, LLC | $209.45 | 2019-2022 | |
| Novo Nordisk INC | $207.41 | 2020-2022 | |
| Amgen INC. | $164.25 | 2019-2022 | |
| Glaxosmithkline, LLC. | $142.83 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $127.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $119.05 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $109.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.88 | 2020-2022 | |
| Amarin Pharma, INC. | $101.30 | 2020-2021 | |
| Clarus Therapeutics INC. | $72.57 | 2021 | |
| Antares Pharma, INC. | $69.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.85 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.80 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $42.01 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $41.61 | 2022 | |
| Astellas Pharma US INC | $41.59 | 2019-2020 | |
| Allergan, INC. | $38.86 | 2020 | |
| Eisai INC. | $36.24 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $24.25 | 2020-2021 | |
| Abbott Laboratories | $23.95 | 2022 | |
| Pfizer INC. | $23.65 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $21.38 | 2021 | |
| Supernus Pharmaceuticals, INC. | $21.34 | 2019 | |
| Almatica Pharma LLC | $19.05 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.57 | 2021 | |
| Horizon Therapeutics Plc | $15.95 | 2020 | |
| Avanir Pharmaceuticals, INC. | $15.31 | 2019 | |
| Boston Scientific Corporation | $12.92 | 2022 | |
| Mylan Specialty L.P. | $12.01 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Baines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.